Join the 'Lifitegrast' group to help and get support from people like you.
Posted 1 Aug 2016 by Drugs.com
July 12, 2016 – The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016. Xiidra is the first medication in a new class of drugs, called lymphocyte function-associated antigen 1 (LFA-1) antagonist, approved by the FDA for dry eye disease. “Normal tear production is needed for clear ...